PMID-sentid Pub_year Sent_text comp_official_name comp_offset protein_name organism prot_offset 7326683-8 1981 Thereby the blockage of glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) by high NADH/NAD-ratios in ischaemic myocardium should be moderated, and ATP production by anaerobic glycolysis stimulated. NAD 81-85 glyceraldehyde-3-phosphate dehydrogenase Canis lupus familiaris 24-64 10506748-8 1999 Treatment of postconfluent cells with agents that deplete ATP diminished the fraction of cytoskeletally associated GAPDH, and levels of insoluble GAPDH were restored with ATP repletion, suggesting that ATP levels may regulate cytoskeletal linkage and thereby local enzyme activity. Adenosine Triphosphate 58-61 glyceraldehyde-3-phosphate dehydrogenase Canis lupus familiaris 115-120 10506748-8 1999 Treatment of postconfluent cells with agents that deplete ATP diminished the fraction of cytoskeletally associated GAPDH, and levels of insoluble GAPDH were restored with ATP repletion, suggesting that ATP levels may regulate cytoskeletal linkage and thereby local enzyme activity. Adenosine Triphosphate 171-174 glyceraldehyde-3-phosphate dehydrogenase Canis lupus familiaris 146-151 10506748-8 1999 Treatment of postconfluent cells with agents that deplete ATP diminished the fraction of cytoskeletally associated GAPDH, and levels of insoluble GAPDH were restored with ATP repletion, suggesting that ATP levels may regulate cytoskeletal linkage and thereby local enzyme activity. Adenosine Triphosphate 171-174 glyceraldehyde-3-phosphate dehydrogenase Canis lupus familiaris 146-151 9015404-2 1996 As the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is inhibited in vitro by reactive oxygen species, we hypothesized that production of reactive oxygen species during reperfusion would lead to inhibition of GAPDH in post-ischaemic myocardium. Reactive Oxygen Species 99-122 glyceraldehyde-3-phosphate dehydrogenase Canis lupus familiaris 25-65 9015404-2 1996 As the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is inhibited in vitro by reactive oxygen species, we hypothesized that production of reactive oxygen species during reperfusion would lead to inhibition of GAPDH in post-ischaemic myocardium. Reactive Oxygen Species 99-122 glyceraldehyde-3-phosphate dehydrogenase Canis lupus familiaris 67-72 9015404-2 1996 As the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is inhibited in vitro by reactive oxygen species, we hypothesized that production of reactive oxygen species during reperfusion would lead to inhibition of GAPDH in post-ischaemic myocardium. Reactive Oxygen Species 99-122 glyceraldehyde-3-phosphate dehydrogenase Canis lupus familiaris 230-235 9015404-2 1996 As the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is inhibited in vitro by reactive oxygen species, we hypothesized that production of reactive oxygen species during reperfusion would lead to inhibition of GAPDH in post-ischaemic myocardium. Reactive Oxygen Species 159-182 glyceraldehyde-3-phosphate dehydrogenase Canis lupus familiaris 25-65 9015404-2 1996 As the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is inhibited in vitro by reactive oxygen species, we hypothesized that production of reactive oxygen species during reperfusion would lead to inhibition of GAPDH in post-ischaemic myocardium. Reactive Oxygen Species 159-182 glyceraldehyde-3-phosphate dehydrogenase Canis lupus familiaris 67-72 9015404-2 1996 As the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is inhibited in vitro by reactive oxygen species, we hypothesized that production of reactive oxygen species during reperfusion would lead to inhibition of GAPDH in post-ischaemic myocardium. Reactive Oxygen Species 159-182 glyceraldehyde-3-phosphate dehydrogenase Canis lupus familiaris 230-235 9015404-11 1996 CONCLUSIONS: These results suggest that inhibition of GAPDH activity may represent an important point at which glycolysis is limited during reperfusion, and further, that the mechanisms of enzyme inhibition do not involve simple oxidation or S-thiolation of critical active site thiol groups. Sulfhydryl Compounds 244-249 glyceraldehyde-3-phosphate dehydrogenase Canis lupus familiaris 54-59 15914110-6 2005 Oxfenicine also prevented HF-induced transcriptional down-regulation of CPT-I, medium chain acyl-CoA dehydrogenase, GAPDH and citrate synthase, key enzymes of cardiac energy metabolism. 4-hydroxyphenylglycine 0-10 glyceraldehyde-3-phosphate dehydrogenase Canis lupus familiaris 116-121 11087255-12 2000 Analyses of glucose uptake and glycolytic intermediates revealed sustained enhancement of glycolysis by low-dose dobutamine, but glycolysis became limited at glyceraldehyde 3-phosphate dehydrogenase during high-dose dobutamine treatment. Dobutamine 216-226 glyceraldehyde-3-phosphate dehydrogenase Canis lupus familiaris 158-198 1975532-0 1990 Influence of Ca/Na exchange and diamide on membrane partitioning of glyceraldehyde-3-phosphate dehydrogenase in dog red cells. Diamide 32-39 glyceraldehyde-3-phosphate dehydrogenase Canis lupus familiaris 68-108 1975532-6 1990 The band representing glyceraldehyde-3-phosphate dehydrogenase was selectively increased under the very same ionic conditions that result in a diamide-induced stimulation of Ca/Na exchange. Diamide 143-150 glyceraldehyde-3-phosphate dehydrogenase Canis lupus familiaris 22-62 1975532-8 1990 Glyceraldehyde-3-phosphate dehydrogenase may participate in the modulation by diamide of Ca/Na exchange in dog red cells. Diamide 78-85 glyceraldehyde-3-phosphate dehydrogenase Canis lupus familiaris 0-40 7326683-8 1981 Thereby the blockage of glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) by high NADH/NAD-ratios in ischaemic myocardium should be moderated, and ATP production by anaerobic glycolysis stimulated. NAD 81-85 glyceraldehyde-3-phosphate dehydrogenase Canis lupus familiaris 66-71 7326683-8 1981 Thereby the blockage of glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) by high NADH/NAD-ratios in ischaemic myocardium should be moderated, and ATP production by anaerobic glycolysis stimulated. NAD 86-90 glyceraldehyde-3-phosphate dehydrogenase Canis lupus familiaris 24-64 7326683-8 1981 Thereby the blockage of glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) by high NADH/NAD-ratios in ischaemic myocardium should be moderated, and ATP production by anaerobic glycolysis stimulated. NAD 86-90 glyceraldehyde-3-phosphate dehydrogenase Canis lupus familiaris 66-71 7326683-8 1981 Thereby the blockage of glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) by high NADH/NAD-ratios in ischaemic myocardium should be moderated, and ATP production by anaerobic glycolysis stimulated. Adenosine Triphosphate 146-149 glyceraldehyde-3-phosphate dehydrogenase Canis lupus familiaris 66-71 29072876-7 2017 Using ELISA, anti-GAPDH IgG was detected in 36% (9/25) of SDH dogs and 69.2% (9/13) of the CDH dogs compared to healthy controls (0/17) (P < 0.0005). sdh 58-61 glyceraldehyde-3-phosphate dehydrogenase Canis lupus familiaris 18-23 29072876-7 2017 Using ELISA, anti-GAPDH IgG was detected in 36% (9/25) of SDH dogs and 69.2% (9/13) of the CDH dogs compared to healthy controls (0/17) (P < 0.0005). cdh 91-94 glyceraldehyde-3-phosphate dehydrogenase Canis lupus familiaris 18-23